학술논문
Tissue plasminogen activator for the treatment of adults with critical COVID-19: A pilot randomized clinical trial.
Document Type
Article
Author
Rashidi, Farid; Barco, Stefano; Rezaeifar, Parisa; Sadeghipour, Parham; Ghodrati, Samad; Bakhshandeh, Hooman; Mousavi-Aghdas, Seyed Ali; Sadeghi, Armin; Sharifi, Akbar; Valizadeh, Hamed; Mikaeili, Haleh; Rafiee, Farnaz; Navarbaf, Zahar; Farajian, Gita; Mahmoodpoor, Ata; Bikdeli, Behnood; Ansarin, Khalil
Source
Subject
*TISSUE plasminogen activator
*THROMBOLYTIC therapy
*COVID-19
*CLINICAL trials
*ADULT respiratory distress syndrome
*
*
*
*
Language
ISSN
0049-3848
Abstract
• Widespread microthrombosis is considered as an etiology for impaired oxygenation in patients with COVID-19 with ARDS. • Systemic thrombolytic versus prophylactic- and therapeutic-dose anticoagulation were compared in present study. • Systematic thrombolytic therapy did not improve oxygenation in critically ill patients with COVID-19. [ABSTRACT FROM AUTHOR]